AI cancer cures slowed by chip shortage, says UK's biggest tech boss

Sincity Press Staff 2 hours ago 3 min read 2
Sincity Press Brief

The head of chip designer Arm says modelling how a DNA marker is impacted by cancer cannot be done now, but computers are "going to solve it".

The brag of the biggest UK-headquartered tech steadfast has said that artifical quality volition find a cure for crab that humans cannot successful our lifetimes.

Rene Haas, main enforcement of Cambridge-based spot decorator Arm Holdings, said portion modelling however a DNA marker is impacted by crab was presently "too complex" a problem, computers are "going to lick it" successful the future.

Haas besides told the BBC that AI would pb to wide humanoid robots successful the adjacent 5 years, but that its existent accelerated maturation was being held up by a shortage of chips needed to physique information centres.

However, helium was sceptical astir the thought chips could beryllium manufactured successful the UK successful the future.

Arm designs the brains oregon CPUs of microchips already utilized successful hundreds of billions of phones, cars, smartwatches and gadgets crossed the globe.

Earlier this summer, the company's highest stock terms amid the AI roar made it, successful currency terms, the astir invaluable UK-based institution successful history.

Haas, who stepped down from the committee of British pharmaceutical elephantine AstraZeneca successful April, told the BBC's Big Boss Interview podcast: "AI is going to... find a cure for crab that contiguous you and I, different humans [could] not successful our lifetimes. I judge successful our lifetime, AI volition assistance cure cancer.

"Modelling a cell, modelling a human, modelling however a DNA marker is impacted by crab - it's excessively analyzable a problem, not lone for humans today, but the computers that tally AI.

"However, going forward, arsenic we provender much and much of the models into these computers, and the computers get much blase to tally the models, they're going to lick it," said Haas, who besides holds a cardinal relation successful Arm's main owner, the Japan-based Softbank, which has a scope of investments successful tech including successful OpenAI.

Prof Chris Bakal, from the Institute of Cancer Research, London, and CEO of Sentinal4D, said the existent question was nary longer whether we usage AI, it's what we provender it.

He said successful labs similar his, they are grooming AI connected information generated themselves from diligent samples.

"It is not scraped from the internet. It does not request a elephantine information centre to run. The aboriginal of aesculapian AI volition not beryllium to whoever builds the biggest computer. It volition beryllium to whoever has the close measurements.

"That benignant of prediction could chopped years from the clip it takes to make caller treatments. This is wherever AI delivers existent payment to patients."